Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.72 $189,273 - $324,468
450,651 Added 8.79%
5,574,850 $3.51 Million
Q3 2023

Nov 13, 2023

BUY
$0.6 - $1.53 $187,382 - $477,825
312,304 Added 6.49%
5,124,199 $3.07 Million
Q2 2023

Aug 11, 2023

BUY
$1.05 - $1.63 $366,242 - $568,547
348,802 Added 7.82%
4,811,895 $5.44 Million
Q1 2023

May 15, 2023

BUY
$1.2 - $2.73 $230,492 - $524,370
192,077 Added 4.5%
4,463,093 $6.03 Million
Q4 2022

Feb 13, 2023

BUY
$1.71 - $3.61 $414,596 - $875,258
242,454 Added 6.02%
4,271,016 $7.94 Million
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $440,613 - $2 Million
231,902 Added 6.11%
4,028,562 $9.91 Million
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $1.16 Million - $4.92 Million
545,526 Added 16.78%
3,796,660 $9.26 Million
Q1 2022

May 13, 2022

SELL
$6.28 - $15.59 $1.8 Million - $4.46 Million
-286,049 Reduced 8.09%
3,251,134 $25.9 Million
Q4 2021

Feb 11, 2022

BUY
$14.7 - $28.67 $3.22 Million - $6.28 Million
219,170 Added 6.61%
3,537,183 $54 Million
Q3 2021

Nov 12, 2021

BUY
$24.31 - $33.6 $1.43 Million - $1.98 Million
58,868 Added 1.81%
3,318,013 $94.3 Million
Q2 2021

Aug 13, 2021

BUY
$26.09 - $40.4 $22 Million - $34.1 Million
844,045 Added 34.95%
3,259,145 $110 Million
Q1 2021

May 12, 2021

BUY
$33.06 - $56.93 $11.2 Million - $19.3 Million
338,577 Added 16.3%
2,415,100 $92.3 Million
Q4 2020

Feb 12, 2021

BUY
$39.09 - $57.4 $11.8 Million - $17.4 Million
302,550 Added 17.05%
2,076,523 $86.8 Million
Q3 2020

Nov 13, 2020

BUY
$28.43 - $44.67 $2.79 Million - $4.39 Million
98,180 Added 5.86%
1,773,973 $76.9 Million
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $4.74 Million - $12.3 Million
405,117 Added 31.88%
1,675,793 $50.8 Million
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $742,776 - $2.67 Million
97,222 Added 8.29%
1,270,676 $17.4 Million
Q4 2019

Feb 13, 2020

BUY
$15.02 - $20.57 $562,273 - $770,037
37,435 Added 3.3%
1,173,454 $18.9 Million
Q3 2019

Nov 12, 2019

BUY
$18.85 - $27.5 $468,837 - $683,980
24,872 Added 2.24%
1,136,019 $21.9 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $3.13 Million - $4.74 Million
180,475 Added 19.39%
1,111,147 $26.1 Million
Q1 2019

May 14, 2019

BUY
$10.65 - $25.75 $2.52 Million - $6.09 Million
236,653 Added 34.1%
930,672 $21.8 Million
Q4 2018

Feb 13, 2019

BUY
$9.26 - $16.38 $768,607 - $1.36 Million
83,003 Added 13.58%
694,019 $7.68 Million
Q3 2018

Nov 13, 2018

BUY
$7.54 - $18.31 $471,883 - $1.15 Million
62,584 Added 11.41%
611,016 $10.2 Million
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $1.03 Million - $1.79 Million
212,291 Added 63.16%
548,432 $4.03 Million
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $210,637 - $451,365
44,912 Added 15.42%
336,141 $1.58 Million
Q4 2017

Feb 13, 2018

BUY
$7.86 - $9.99 $74,355 - $94,505
9,460 Added 3.36%
291,229 $2.64 Million
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $209,599 - $245,200
23,577 Added 9.13%
281,769 $2.64 Million
Q2 2017

Aug 14, 2017

BUY
N/A
258,192
258,192 $2.47 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.